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The Solution Structure of Heparan Sulfate Differs from That
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Background: The polysaccharide heparan sulfate (HS) exhibits key physiological roles.
Results: Analytical ultracentrifugation and x-ray scattering revealed extended but bent HS solution structures.
Conclusion: Scattering fits resulted in molecular models for HS in solution with glycosidic angles in good accord with a HS
crystal structure.
Significance: These bent HS models clarify how HS interacts with its ligands.
The highly sulfated polysaccharides heparin and heparan
sulfate (HS) play key roles in the regulation of physiological
and pathophysiological processes. Despite its importance, no
molecular structures of free HS have been reported up to now.
By combining analytical ultracentrifugation, small angle x-ray
scattering, and constrained scattering modeling recently used
for heparin, we have analyzed the solution structures for eight
purified HS fragments dp6–dp24 corresponding to the pre-
dominantly unsulfated GlcA-GlcNAc domains of heparan sul-
fate. Unlike heparin, the sedimentation coefficient s20,w of HS
dp6–dp24 showed a small rotor speed dependence, where sim-
ilar s20,w values of 0.82–1.26 S (absorbance optics) and1.05–1.34
S (interference optics) were determined. The corresponding
x-ray scattering measurements of HS dp6–dp24 gave radii of
gyration RG values from 1.03 to 2.82 nm, cross-sectional radii of
gyrationRXS values from0.31 to 0.65 nm, andmaximum lengths
L from 3.0 to 10.0 nm. These data showed that HS has a longer
and more bent structure than heparin. Constrained scattering
modeling starting from 5,000 to 12,000 conformationally ran-
domizedHS structures gave best fit dp6–dp24molecular struc-
tures that were longer and more bent than their equivalents in
heparin. Alternative fits were obtained for HS dp18 and dp24,
indicating their higher bending and flexibility. We conclude
that HS displays bent conformations that are significantly dis-
tinct from that for heparin. The difference is attributed to the
different predominant monosaccharide sequence and reduced
sulfation of HS, indicating that HSmay interact differently with
proteins compared with heparin.
Heparan sulfate (HS)2 is a sulfated glycosaminoglycan that is
found extensively on animal cell surfaces and other extracellu-
lar surfaces (1, 2). HS has key roles in biological recognition
processes at the cell-tissue-organ interface through its interac-
tions with a wide range of proteins (3, 4). Specific interactions
involving HS include roles in cell growth and development (5),
cell adhesion (6), inflammation and wound healing (7), angio-
genesis and cancer (8–10), viral invasion (11, 12), and antico-
agulation (13). The breadth of these HS-protein interactions
offers potential strategies for therapeutic intervention at the
cell-tissue-organ interface.
HS is a sulfated polysaccharide composed of uronic acid and
D-glucosamine residue pairs linked by (134)-glycosidic bonds
(Fig. 1) (14, 15). The uronic acid residue is either unmodified
-D-glucuronic acid (-GlcA), alternating with N-acetylated
glucosamine (Fig. 1A), or -L-iduronic acid (-IdoA), often
2-O-sulfated, alternating withN-sulfated glucosamine (GlcNS)
(Fig. 1B). In the latter, sulfation often occurs at C6 and rarely
also at C3 (16, 17). HS has a distinct domain organization that is
comprised of short S domains (IdoA2S and GlcNS residues),
long NA domains with GlcA and GlcNAc residues, and mixed
domain regions at the junctions between the S domains andNA
domains (15, 16). The S domains andmixed domain regions are
termed the hypervariable regions that result in different func-
tional characteristics for HS from different cell types (16).
Three-dimensional structural studies of HS are required to
complete an understanding of the physiological significance of
HS-protein interactions. Many structural studies have been
carried out for heparin, which is an analog for HS but possesses
a higher degree of sulfation, being predominantly S region-like
in sequence, and for at least 19 heparin-protein co-crystal com-
plexes. This abundance results because of the ease with which
heparin is obtained and its strong binding to many of the cell
surface proteins whose physiological ligand is HS. An NMR
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structure is known for heparin (18). Solution structures are
known for six purified fragments dp6-dp36 of heparin from
constrained scatteringmodeling; these forms were shown to be
similar in conformation to heparin when observed in heparin-
protein crystal structures (19). In distinction, up to now, no
molecular structures for free HS are known, and only one crys-
tal structure at 0.21-nm resolution for a dp4HS oligosaccharide
complexed with heparinase II is available (20).
Given the importance of understanding the HS solution
structure, we have used a multidisciplinary approach to deter-
mine molecular structures for HS based on the combination of
three methods, namely analytical ultracentrifugation, small
angle x-ray scattering, and constrained scatteringmodeling (21,
22). This approach is well established for solution structure
determinations of large multidomain complement and anti-
body proteins and was recently applied to small heparin oligo-
saccharide fragments (19, 23). Here, we apply this approach for
the second time for oligosaccharide solution structures, this
time for eight HS fragments ranging in sizes from dp6 to dp24,
thus permitting detailed comparisons with heparin. The HS
fragments exhibited solution structures that were distinct from
those of the heparin fragments. In particular, their overall
lengths are longer compared with heparin, and their structures
display a greater degree of bending with increase in size com-
pared with heparin. Our results are attributed to the difference
in monosaccharide sequence between HS and heparin frag-
ments, combined with a much reduced degree of sulfation in
the HS fragments, which possessed greater structural flexibility
than heparin. These results provided new insight on the poten-
tial binding modes of HS to proteins.
Following publication of our original 2011 study, we regret-
tably discovered an error in the anomeric configuration of our
heparan sulfate structural models. This present study super-
sedes the 2011 study, which has been withdrawn.
EXPERIMENTAL PROCEDURES
Purification ofHS Fragments—HSoligosaccharide fragments
were prepared according to a similar method to that previously
used for heparin oligosaccharides (19, 24–26). Exhaustive
heparinase digestion was used to minimize the content of fully
sulfated sequences. Approximately 100 mg of HS (prepared
from a crude glycosaminoglycanmixture, the kind gift of Labo-
ratori Derivati Organici, Italy: a mixture of HS-I and HS-II as
described in Ref. 27) was weighed out and dissolved in2ml of
phosphate buffer, pH 7. An aliquot of 200 l of heparinase I
stock solutionwas added and left to digest at room temperature
for at least 2 h, long enough for the reaction to run to comple-
tion. The reaction mixture was evaporated to dryness, using a
rotary evaporator at 50 °C.
To isolate theHS fragments, the dried digest was dissolved in
1.5 ml of 2% ammonium bicarbonate solution and filtered
through a 0.45-micron syringe filter before injection onto the
preparative gel filtration column. The filtered digested HS was
then applied to a preparative gel permeation chromatography
column (100 1.6 cm; packed with Biogel P10) (Bio-Rad). The
HS fragments were eluted using 2% ammonium bicarbonate at
a flow rate of 0.2 ml/min in 2-ml fractions. The absorbance of
the fractions was measured at 234 nm, and the top fractions
corresponding to each individual resolved peak were pooled.
The HS oligosaccharides larger than dp12 were not completely
resolved (Fig. 2). The pooled fractions were evaporated under
reduced pressure and lyophilized before assessment of their
sizes by analytical gel permeation chromatography (25). Like
heparin, gel permeation chromatography was carried out using
two columns (TSK G3000 SW-XL, 30 cm; TSK G2000 SW-XL,
30 cm; Anachem) connected in series. The eluant was 0.1 M
ammoniumacetate solution at a flow rate of 0.5ml/min, andHS
was detected with a refractive index detector (RI-1530; Jasco).
The chromatography system was calibrated using the First
International Reference Reagent Low Molecular Weight Hep-
arin for Molecular Weight Calibration (NIBSC 90/686). HS
quantizationwas achieved by integration of the area under each
refractive index peak and comparison with a standard curve
prepared using known concentrations of low molecular weight
FIGURE 1. Chemical structures of the two disaccharide repeats of HS and
heparin. A, the major repeating disaccharide unit of HS (glucuronic acid3
N-acetylglucosamine). The NHCOCH3 group in the second ring is replaced
byNHSO3
 in 50%of this structure. The resultingmolecularmass of this aver-
aged disaccharide is 483 Da. B, the minor repeating unit of HS, which is the
major repeating disaccharide unit in 90% of heparin (iduronic acid-2-sulfate3
glucosamine-2,6-disulfate). For comparison with this study, heparin is consid-
ered tobe50% in the trisulfate formas shownand50% in adisulfate formwhere
asulfategroup is lost. The resultingmolecularmassof thisaverageddisaccharide
is 628Da.
FIGURE 2. Purification profile of the HS fragments. The HS fragments were
elutedwith a flow rate of 0.2ml/min using a Biogel P-10 column in 2%ammo-
niumbicarbonate solution. Fractions of 2ml/10minwere collected, and their
HS concentrations were measured spectrophotometrically at 234 nm. The
fractions taken for this study are shown by open circles. The inset shows 25%
PAGE of the HS fragments dp6–dp24 (labeled as 6–24) with heparin dp24
(labeled as H) as marker. OD, optical density.
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heparin. An absorption coefficient of 5500 M1 cm1 at 232 nm
was used for HS experiments (28).
PAGE ofHS Fragments—TheHS fragments were analyzed by
PAGE to determine the level of purity of each one according to
a previously described method (29). Each HS fragment (5 g)
was mixed with 20% glycerol up to a maximum volume of
10–15 l and then loaded into separate wells (Fig. 2, inset).
Phenol red in 20% glycerol in a maximum volume of 10 l was
also applied to a separate well as a marker. Initially samples
were run through a stacking gel (5% acrylamide, 0.5% bisacryl-
amide) at 150 V for 20–30 min until the phenol red started to
enter the resolving gel. In the resolving gel (25% acrylamide, 1%
bisacrylamide), samples were run at a constant current of 18
mA until the phenol red reached the bottom of the gel. The
discontinuous buffer system of Laemmli (30) consisted of 0.125
M Tris/HCl, pH 6.8, in the stacking gel and 0.375 M Tris/HCl,
pH 8.8, in the resolving gel. The gel running buffer was 25 mM
Tris, 0.192 M glycine, pH 8.3. The gel was stained with 0.08%
aqueous Azure A for 10 min to visualize HS bands. The gel was
then destained in water to remove excess dye and clear the gel
background.
Analytical Ultracentrifugation of HS Fragments—Sedimen-
tation velocity data for eight HS fragments (dp6, dp8, dp10,
dp12, dp14, dp16, dp18, and dp24) were obtained on two Beck-
man XL-I analytical ultracentrifuges (Beckman-Coulter Inc.,
Palo Alto, CA) using both absorbance and interference optics.
Experiments with the dp6–dp24 fragments were performed at
concentrations of 0.5mg/ml in 10mMHEPES and 137mMNaCl
(pH 7.4). The buffer density was measured at 20 °C using an
Anton-Paar DMA5000 density meter to be 1.00480 g/ml. A
partial specific volume of 0.467 ml/g determined for heparin
(31) was used for HS. An alternative higher value of 0.55 ml/g
for HS has been reported elsewhere and was used for data pro-
cessing only when required to confirm that the partial specific
volume has no effect on the outcome of this study (32). Analyt-
ical ultracentrifugation runs were carried out in an eight hole
AnTi50 rotor with standard double-sector cells with column
heights of 12 mm at 20 °C using absorbance optics at 234 nm
and interference optics. Sedimentation velocity data were col-
lected at 40,000, 50,000, and 60,000 rpm using absorbance
optics and interference optics. The continuous c(s) analysis
method was used to determine the sedimentation coefficients
s20,w of the eight HS fragments using SEDFIT software (version
9.4) (33, 34). The c(s) analysis directly fits the experimental sed-
imentation boundaries using the Lamm equation, the algo-
rithm for which assumes that all species have the same fric-
tional ratio f/fo in each fit. The final SEDFIT analyses used a
fixed resolution of 200, and optimized the c(s) fit by floating the
meniscus and cell bottom when required and holding the f/fo
value, base line, and cell bottom fixed until the overall root
mean square deviations and visual appearance of the fits were
satisfactory (Fig. 3). The individual f/fo values calculated previ-
ously for the heparin fragmentswere used for the equivalentHS
fragments (19).
Synchrotron X-ray Scattering of HS Fragments—X-ray solu-
tion scattering of the above eightHS fragments dp6–dp24were
performed on the Beamline ID02 at the European Synchrotron
Radiation Facility at Grenoble, France, in two sessions with a
FIGURE 3. Sedimentation velocity size distribution analyses c(s) of six HS dp6–dp24 fragments. The absorbance and interference boundary scans were
fitted using SEDFIT software for the HS fragments, each at 0.5 mg/ml. Themean s20,w and their standard deviations are reported in Table 1. A, the absorbance
data using awavelength of 234 nm and a rotor speed of 50,000 rpm gave s20,w peaks at 0.84 S for dp6, 0.95 S for dp8, 0.98 S for dp10, 1.08 S for dp12, 1.11 S for
dp18, and 1.23 S for dp24. Beneath these panels, representative boundary fits are shown for dp6 and dp24, in which only every sixth scan of the 120 fitted
boundaries are shown for clarity.B, the interferencedata using a rotor speedof 50,000 rpmgave s20,wpeaks at 1.04 S for dp6, 1.12 S for dp8, 1.11 S for dp10, 1.19
S for dp12, 1.25 S for dp18, and 1.34 S for dp24. Beneath these panels, representative boundary fits are shown for every sixth scan of the 120 fitted boundaries
for dp6 and dp24.
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ring energy of 6.0 GeV (35). In the first session, data were col-
lected for six HS fragments in 16-bunch mode using beam cur-
rents from 63 to 89 mA. In the second session, data were col-
lected for all eight HS fragments in 16-bunchmode using beam
currents from 65 to 78 mA. Data were acquired using an
improved fiber optically coupled high sensitivity and dynamic
range CCD detector (FReLoN) with a smaller beamstop. The
sample to detector distance was 3.0 m. Experiments used the
same HS concentrations of 0.5 mg/ml and buffers used in
the sedimentation velocity experiments. For eachHS fragment,
the samples were measured in a flow cell, which moved the
sample continuously during beam exposure in 10 time frames
with different exposure times of 0.1, 0.25, 0.5, and 1 s to check
for the absence of radiation damage effects. This exposure was
optimized using on-line checks for the absence of radiation
damage to show that this was not detectable.
Guinier analyses give the radius of gyration, RG, which mea-
sures the degree of structural elongation in solution if the inter-
nal inhomogeneity of scatteringwithin themacromolecules has
no effect. Guinier plots at lowQ values (whereQ 4  sin /,
2 is the scattering angle, and  is the wavelength) gives the RG
and the forward scattering at zero angle I(0) (36).
ln IQ ln I0	 RG
2Q2/3 (Eq. 1)
This expression is valid in a QRG range up to 1.5. If the struc-
ture is elongated (i.e., rod-shaped), the radius of gyration of the
cross-sectional structure RXS and the mean cross-sectional
intensity at zero angle [I(Q)Q]Q30 parameters are obtained
from fits in a higher Q range.
ln IQ  Q	 ln IQ  Q	Q3 0	 Rxs
2 Q2/2 (Eq. 2)
The RG and RXS analyses were performed using an interactive
PERL script program SCTPL73 on Silicon Graphics OCTANE
workstations. Indirect Fourier transformation of the full scat-
tering curve I(Q) in reciprocal space gives the distance distribu-
tion function P(r) in real space. This yields the maximum
dimension of the macromolecule L and its most commonly
occurring distance vectorM in real space.
Pr 
1
22 
0


IQQr sinQrdQ (Eq. 3)
The transformation was carried out using GNOM software (37).
For dp6–dp16, the full x-ray I(Q) curves contained 295–343 data
points in similarQ ranges between 0.29 and 1.80 nm1.
Molecular Modeling of HS Fragments—Linear HS models
were created using the crystal structure of the HS tetrasaccha-
ride (dp4) observed in its complexwith heparinase II (PDB code
3E7J) with Discovery Studio (version 2.5) molecular graphics
software (Accelrys, San Diego, CA). The monosaccharide resi-
dues in the HS tetrasaccharide of 3E7J were N-acetyl -D-glu-
cosamine (internal), -D-GlcNAc (reducing terminal), -D-
GlcA (internal), and 4,5-dehydro-D-GlcA (UA; nonreducing
terminal). Unfortunately the PDB three-letter abbreviations
used in 3E7J do not conform to the PDB conventions. The
abbreviationNAG (correctly used only for-D-GlcNAc) is used
for both - and -anomers; the abbreviation GCU (correctly
used only for -D-GlcA) is used for -D-GlcA. In addition, we
also point out that the dp4 structure was written out in the
original crystallography paper (20) as NAG-GCU-NAG-GCD
(where GCD is the PDB code for UA). This order, with the
reducing end to the left, is unconventional. In the current study,
the disaccharide -D-GlcNAc-(134)--D-GlcA, from the two
internal monosaccharides in the 3E7J tetrasaccharide, was
taken to be the base HS structure, and these disaccharide units
(PDB code NDG-BDP) were joined by glycosidic linkages to
generate a fully extended linear HS dp30 structure. In this, the
phi () and psi () angles were maintained at similar values
observed in the starting dp4 structure. Linear HS dp6–dp24
models were created from this extended dp30 startingmodel by
the removal of nonrequired disaccharides.
Totals of 5,000 conformationally randomized models for
each of dp6, dp8, dp10 and dp12, 8,000 similar models for each
of dp14 and dp16, and 12,000 similar models for each of dp18
and dp24 were created starting from each linear model. In the
original HS dp4 structure, the  and  angles were 90° and
124° respectively for the GlcA-GlcNAc (BDP-NDG) disaccha-
ride and 85° and 95° respectively for the GlcNAc-GlcA (NDG-
BDP) disaccharide. These and angles were randomized to
take any value in a maximum range of 45° starting from the
preceding values using the TorsionKick function in a PERL
script that was modified from the ExtractAngle.pl script pro-
vided with the Discovery Studio software. For example, in the
case of dp16, a total of eight  and angles for GlcA-GlcNAc
and seven and angles for GlcNAc-GlcA were randomized
in this way. To avoid steric clashes between the dp16 atoms in
each randomized structure, a constant force field termed
DREIDING minimization provided in Discovery Studio was
used to correct this. DREIDING minimization was useful in
generating structures by providing accurate geometries and
reasonably accurate steric barrier for organic, biological and
inorganic main groups (38).
Constrained Scattering and Sedimentation Coefficient Model-
ing—Each HS model was used to calculate the x-ray scattering
curve for comparison with the experimental curve using Debye
spheremodels (39–41). A cube side length of 0.520 nm in com-
bination with a cutoff of 4 atoms was used to create the spheres
for the HS dp6–dp16models. The hydration shell correspond-
ing to 0.3 g/g H2O was created by adding spheres to the unhy-
drated sphere models using HYPRO (42), where the optimal
total of hydrated spheres is listed in Table 1. The x-ray scatter-
ing curve I(Q) was calculated using the Debye equation as
adapted to spheres and assuming a uniform scattering density
for the spheres (43). Other details are given elsewhere (39–41,
44). X-ray curves were calculated without instrumental correc-
tions as these were considered to be negligible for the pinhole
optics used in synchrotron x-ray instruments. First, the number
of spheresN in the dry and hydratedmodels after grid transfor-
mation was used to assess steric overlap between the HS disac-
charides, where models showing less than 95% of the optimal
totals (see Table 1) were discarded. This procedure was found
to be insensitive to steric overlap in the case of oligosaccharides,3 J. T. Eaton and S. J. Perkins, unpublished software.
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and was discontinued in favor of the DREIDINGminimization
procedure (above). Next, the models were assessed by calcula-
tion of the x-ray RG values from Guinier fits of the modeled
curves using the same Q ranges used for the experimental
Guinier fits to allow for any approximations inherent in the use
of the QRG range up to 1.5. Models that passed the N and RG
filterswere then ranked using a goodness-of-fitR factor to iden-
tify the best fit eight models for each HS fragment.
Sedimentation coefficients s020,w for each of the eight best fit
HS scattering models were calculated directly from molecular
structures using the HYDROPRO shell modeling program (45).
The default value of 0.31 nm for the atomic element radius for all
atoms was used to represent the hydration shell surrounding HS.
Protein Data Bank—The eight best fit dp6–dp24models are
currently available as supplemental materials. They were orig-
inally deposited in the Protein Data Bank with accession codes
of 3QHG (dp6), 3QHH (dp8), 3QHI (dp10), 3QHJ (dp12),
3QHK (dp14), and 3QHL (dp16). The corrected models have
been redeposited with codes of 4KHC (dp6), 4KHD (dp8),
4KHE (dp10), 4KHF (dp12), 4KHG (dp14), 4KHH (dp16), 4KHI
(dp18: extended), 4KHJ (dp18: bent), 4KHK (dp24: extended),
and 4KHL (dp24: bent).
RESULTS
SedimentationVelocityDataAnalysis for EightHSFragments—
The purification profile from the Biogel P-10 column shows
that the four smallest HS fragments dp6–dp12 were eluted as
well resolved peaks, whereas the four larger fragments dp14–
dp18 and dp24 were less well resolved (Fig. 2). Analytical high
performance size exclusion chromatography of the HS oligo-
saccharide fractions as described (25), and PAGE was per-
formed to show that all eight peak fractions showed altered
sizes as expected and were relatively homogenous in size. Pro-
ton NMR spectroscopy (not shown) showed that the
GlcA-GlcNAc disaccharide was the predominant structure
present with a minor content of sulfated saccharide residues,
presumably originating from transition sequences between the
NA and S domains. Signals typical of heparin-like S domains
were almost completely absent.
Analytical ultracentrifugation studies macromolecular struc-
tures and sizes through quantitativemeasurements of sedimen-
tation rates in a high centrifugal field (46). Sedimentation veloc-
ity experiments at three rotor speeds were performed for the
eight HS fragments (dp6–dp18 and dp24) to determine their
shapes and degree of polydispersity. The sedimentation coeffi-
cient distribution function c(s) was calculated by direct fitting
of the sedimentation boundaries using SEDFIT software. The
absorbance optics analyses for each HS fragment reproducibly
resulted in good boundary fits that resulted in single major
peaks (Fig. 3A). Themean sedimentation coefficient s20,w values
at three speeds ranged from 0.82 0.05 S for dp6 to 1.26 0.08
S for dp24. The corresponding interference optics analyses for
dp6–dp24 also resulted in good boundary fits and single major
c(s) peaks withmean s20,w values that ranged from 1.05 0.04 S
for dp6 to 1.35 0.04 S for dp24 (Fig. 3B). The comparisons in
Fig. 4 indicate that the difference between the absorbance and
interference s20,w values results from statistical variability, and
there is no bias between the two data sets. The number of peaks
and their widths assess the polydispersity of each HS fragment.
In this regard, both the absorbance and interference optics
showed better resolution and single narrower major peaks
when comparedwith the equivalent data sets for heparin (Fig. 3
in Ref. 19). The most likely explanation for this appears to be
variability in the sulfate content within the heparin fragments,
causing variations inmass that resulted in a broader peakwidth.
This effect would not be present in HS because of the reduced
sulfation level in HS. The similar single peak widths from either
absorbance or interference optics suggest that all eight HS frag-
ments showed narrow size distributions and are relatively
homogenous, in agreement with the chromatography results
above. The smaller HS fragments show slightly broader peak
widths than the larger ones, and this is attributed to a higher
back diffusion effect. Unlike heparin, a slight decrease in the
s20,w values of the absorbance and interference data were
observed with increase of rotor speed; this indicated that the
s20,w values depend on the rotor speed (Fig. 4,A and B). Inspec-
tion of the boundary fits showed that this slight rotor speed
dependence resulted from a contribution from back diffusion
in the c(s) fits that was reduced with increase in rotor speed.
Accordingly, although the values at the highest speed were
taken to be more valid, they were within error of the averaged
values (Table 1).
Like heparin, the HS analyses revealed s20,w values that
increasedwith an increase in size of the fragments (Fig. 4,A and
B). A typical molecular mass of the most abundant HS dp2
structure shown in Fig. 1A is 483 Da, whereas the correspond-
ing value for heparin dp2 is 628 Da (Fig. 1A of Ref. 19). Because
of the differences in molecular size, the Svedberg equation pre-
dicts that the s20,w values of the HS fragments will be 77% of
those for the equivalently sized heparin fragments. The mean
s20,w value for HS dp24 is 1.30 0.06 S (Table 1), which is 86
8% of the corresponding value for heparin dp24 of 1.52 0.07 S
(Table 1 of Ref. 19). This is almost within error of the mass-
predicted reduction in s20,w value. If real, the difference
between the 77 and 86% values would correspond to a 10%
smaller frictional coefficient forHS comparedwith heparin, i.e.,
HS may have a slightly more compact solution structure than
heparin.
The sedimentation coefficient s020,w values were calculated
using HYDROPRO software frommolecular models of HS. For
this, 13 linear HS models (dp6–dp30) were computed starting
from the HS dp4 crystal structure seen in its complex with
heparinase II (20). Even though the rate of increase of the s020,w
values with size was predicted correctly, the theoretical s020,w
values for HS were consistently lower than those seen experi-
mentally (Fig. 4, A and B). The theoretical values for the HS
fragments were consistently lower when compared with their
experimental values and therefore show that HS sediments
more rapidly than predicted, i.e., the overall solution structures
are more compact through bending than the linear HS struc-
tures. Below, this difference in Fig. 4 is explained by the best fit
bent HS structures that weremodeled from the scattering data.
It is noteworthy that this difference between experimental and
theoretical values was not seen for heparin (19); this shows that
the HS and heparin solution structures are different. In addi-
tion, the linear HS and heparin structures differ in their degree
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of elongation. The theoretical s020,w value for a linear HS struc-
ture is 70% lower than the corresponding theoretical value for a
linear heparin structure, in reflection of a longer linear HS
structure.
X-ray Solution Scattering Data for Eight HS Fragments—So-
lution scattering is a diffraction technique that provides struc-
tural information on biological macromolecules in randomori-
entations in solution (21, 22). To complement the analytical
ultracentrifugation data in more detail, the solution structures
of the same eight HS fragments dp6–dp24 at 0.5 mg/ml were
characterized by synchrotron x-ray scattering. The scattering
experiments reports the scattering curve I(Q) as a function of
scattering angle Q. Tests for possible radiation damage effects
(“Experimental Procedures”) showed that theywere not detect-
able; accordingly data were acquired with the longest exposure
time of 1 s to maximize signal:noise ratios. Guinier analyses of
ln I(Q) versusQ2 at lowQ values gives the radius of gyration,RG,
which monitors the degree of macromolecular elongation.
Because of the very different sizes of theHS fragments, different
Q ranges were required for each fragment to work within
acceptable linear QRG ranges (Fig. 5A). Thus the Guinier fit Q
range of 0.4 to 0.8 nm1 for dp6 was successively reduced in
stages to that of 0.28–0.55 nm1 for dp24 (Fig. 5A). The mean
Guinier RG values increased from 1.03 0.08 nm for dp6 up to
2.82 0.10 nm for dp24 (Table 1). TheseRG values for the eight
HS fragments do not show a linear relationship with the size of
the HS fragments, unlike the RG values calculated from linear
models, showing reduced values instead (Fig. 6A). Thus the
comparison of the RG values between the linear models and the
experimental data also showed that theHS fragmentswere bent
in solution. In addition, the experimental HS RG values are
larger for the dp18–dp36 fragments than those seen for the
heparin dp18 and dp24 fragments (Fig. 6A). This shows that HS
has a more elongated structure than that for heparin.
Macromolecules that are sufficiently elongated in shape will
show a cross-sectional radius of gyration RXS value. The RXS
value monitors the degree of bending within the macromolec-
ular length. As for theRG analyses, differentQ ranges were used
for the RXS fits for the different HS fragments depending on the
size of the HS fragment, all of which were larger than the Q
ranges used for theRG analyses (Fig. 5B). In all cases, despite the
worsened signal:noise ratios of the I(Q) data, linear fit ranges
were identified in the plots of ln I(Q)Q versus Q2. These ranges
gave experimental RXS values of 0.31 nm for dp6 that increased
FIGURE 4. Comparison of the experimental and predicted sedimentation coefficients for eight HS dp6–dp24 fragments. The filled circles (F) and
triangles (Œ) represent the experimental values for dp6–dp24. The open circles (E) represent the predicted values for linear dp6-dp30models. For comparison,
the equivalent heparin experimental data from Ref. 19 is shown as dotted lines in A and B. A, comparison with the experimental sedimentation coefficients at
rotor speeds of 40,000 (‚), 50,000 (F), and 60,000 () rpm using absorbance optics. B, comparison with the experimental sedimentation coefficients at rotor
speedsof 40,000 (‚), 50,000 (F), and60,000 () rpmusing interferenceoptics.C, the linearmodels forHSdp6–dp24 thatwere created starting fromtheHSdp4
crystal structure (PDB code 3E7J) are shown.
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up to 0.65 nm for dp24 (Fig. 6B and Table 1). This increase in
the RXS values correlated with the deviation of the RG values
from linearity (Fig. 6A). They were larger than the calculated
RXS values of 0.40 nm for the linear HS dp6-dp30 models, thus
supporting the conclusion that the HS fragments become pro-
gressively more bent with an increase in size. Combination of
the RG and RXS values according to the relationship L2  12
(RG2  RXS2) for an elliptical cylinder (36) showed that HS
dp6, dp8, dp10, dp12, dp14, dp16, dp18, and dp24 have approx-
imate lengths of 3.4, 3.9, 4.6, 5.5, 5.8, 6.8, 7.8, and 9.5 nm in that
order. Similar lengths of 7.0, 9.1, 9.6, and 10.7 nmwere observed
for the heparin dp18, dp24, dp30, and dp36 fragments (19). In
conclusion, the comparison of the dp18 and dp24 lengths
showed that HS has a longer structure than that of heparin, in
addition to being more bent than heparin.
The distance distribution function P(r) is calculated from the
full Q range of the I(Q) scattering curve (“Experimental Proce-
dures”). The P(r) curve represents the distribution of all the
distances between the atoms within the macromolecule. This
provides RG values and model-independent determinations of
the overall length, L, following an assumption of the maximum
dimension, Dmax (Fig. 6C); note that L is not a contour length.
The mean RG values obtained from the P(r) curves increase
from 0.98 0.05 nm for dp6 to 3.0 0.05 nm for dp24 (Table
1). These P(r) RG values are in excellent accord with the corre-
sponding Guinier RG values from the low Q values and follow
the same trends with size (Table 1 and Fig. 6A). Model-inde-
pendentL values are determined from the r valuewhere theP(r)
curve reaches zero at large r. These experimental L values were
3.0 nm for dp6, 3.5 nm for dp8, 4.5 nm for dp10, 5.5 nm for
dp12, 6.0 nm for dp14, 7.0 nm for dp16, 8.5 nm for dp18, and
10.0 nm for dp24. These values show increasing deviation with
size from the longer lengths measured for the linear HS dp6–
dp24 models (i.e., 3.0 nm for dp6, 3.9 nm for dp8, 4.4 nm for
dp10, 5.7 nm for dp12, 7.0 nm for dp14, 8.5 nm for dp16, 8.9 nm
for dp18, and 11.0 nm for dp24), noting that a hydration shell of
thickness 0.6 nm (2  0.3 nm) is added to these linear model
lengths (44). These experimental L values from the P(r) curves
are more accurate compared with the approximate L values
calculated from theRG andRXS values that assumed an elliptical
TABLE 1
X-ray scattering and sedimentation coefficient modeling fits for eight HS fragments
HS fragment Filter Number of models Hydrated spheresa RG b RXS R factor Length (L) s20,wc
nm nm % nm S
dp6 None 5,000 8–21 0.71–1.06 0.01–0.44 4.0–9.0 NA NA
RG, RXS, R factor 8 18–19 1.01–1.03 0.30–0.32 4.4–4.6 3.0–3.1 0.47–0.53
Best fit 1 19 1.02 0.31 4.4 3.1 0.53
Experimental 1.03 0.08 0.31 0.06 3.0 0.82 0.05
0.98 0.05 1.05 0.04
dp8 None 5,000 13–28 0.92–1.36 0.10–0.55 4.4–8.3 NA NA
RG, RXS, R factor 8 17–24 1.18–1.20 0.40 4.5 3.5–3.8 0.61–0.62
Best fit 1 21 1.19 0.40 4.5 3.8 0.61
Experimental 1.19 0.08 0.40 0.03 3.5 0.94 0.06
1.16 0.02 1.06 0.08
dp10 None 5,000 16–35 1.03–1.55 0.32–0.68 4.4–11.2 NA NA
RG, RXS, R factor 8 25–29 1.40–1.42 0.43–0.44 4.4 4.5–5.0 0.67–0.68
Best fit 1 28 1.41 0.44 4.4 4.6 0.67
Experimental 1.41 0.07 0.44 0.04 4.5 0.95 0.09
1.37 0.04 1.09 0.06
dp12 None 5,000 19–42 1.10–1.75 0.12–0.78 4.2–12.8 NA NA
RG, RXS, R factor 8 30–40 1.63–1.65 0.48–0.50 4.2–4.5 5.5–5.7 0.74
Best fit 1 37 1.63 0.5 4.4 5.5 0.74
Experimental 1.65 0.09 0.49 0.04 5.5 1.08 0.09
1.62 0.03 1.16 0.05
dp14 None 8,000 21–45 1.20–2.01 0.09–0.81 4.2–11.7 NA NA
RG, RXS, R factor 8 35–39 1.73–1.76 0.48–0.49 4.3 6.0–6.3 0.82–0.83
Best fit 1 37 1.73 0.49 4.3 6.1 0.82
Experimental 1.76 0.07 0.51 0.02 6.0 1.07 0.07
1.82 0.09 1.18 0.04
dp16 None 8,000 27–54 1.22–2.25 0.01–0.93 6.5–16.2 NA NA
RG, RXS, R factor 8 41–48 1.93–2.00 0.49–0.51 6.5–6.6 6.4–7.2 0.86–0.89
Best fit 1 42 2.0 0.47 6.5 7.2 0.88
Experimental 2.03 0.07 0.52 0.01 7.0 1.10 0.03
2.11 0.11 1.24 0.08
dp18 None 12,000 29–60 1.32–2.43 0.01–1.00 5.4–20.2 NA NA
RG, RXS, R factor (extended) 8 45–49 2.24–2.29 0.39–0.48 6.2–7.1 8.0–8.5 0.90–0.92
Best fit (extended) 1 48 2.25 0.48 6.2 8.5 0.92
R factor (bent) 8 45–53 2.03–2.15 0.38–0.60 5.4–5.6 6.5–7.0 0.92–0.94
Best fit (bent) 1 46 2.13 0.47 5.4 7.0 0.92
Experimental 2.34 0.03 0.61 0.05 8.5 1.12 0.06
2.44 0.11 1.25 0.07
dp24 None 12,000 42–77 1.49–2.85 0.01–1.18 4.6–18.9 NA NA
RG, RXS, R factor (extended) 8 61–64 2.68–2.78 0.52–0.58 6.6–7.9 9.0–10.0 0.91–1.0
Best fit (extended) 1 61 2.70 0.53 6.6 9.0 0.96
R factor (bent) 8 59–72 2.44–2.59 0.39–0.50 4.6–4.8 8.0–9.0 0.78–1.07
Best fit (bent) 1 63 2.47 0.57 4.6 8.5 1.07
Experimental 2.82 0.10 0.65 0.05 10.0 1.26 0.06
3.0 0.05 1.34 0.06
a The optimal totals of hydrated spheres were 15 for dp6, 20 for dp8, 25 for dp10, 30 for dp12, 34 for dp14, 39 for dp16, 44 for dp18, and 59 for dp24.
b The first experimental value is from the Guinier RG analyses, and the second one is from the GNOM P(r) analyses.
c The averaged experimental s20,w value is reported, the first value being from the absorbance (234 nm) data sets and the second value being from the interference data sets.
The absorbance and interference data were recorded at rotor speeds of 40,000, 50,000, and 60,000 rpm.
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FIGURE 5. Experimental Guinier x-ray scattering analyses of eight HS dp6–dp24 fragments. A, Guinier RG plots for dp6–dp24 at concentrations of 0.5
mg/ml. The filled circles were used to determine the radius of gyration RG, based on the best fit lines as shown. The Q ranges used for the RG analyses were
0.40–0.8 nm1 for dp6, 0.42–0.78 nm1 for dp8, 0.34–0.74 nm1 for dp10, 0.30–0.66 nm1 for dp12, 0.30–0.64 nm1 for dp14, 0.29–0.55 nm1 for dp16,
0.28–0.55 nm1 for dp18, and 0.28–0.55 nm1 for dp24. B, Guinier RXS plots for dp6–dp24. The filled circles represent the Q ranges used to determine the
cross-sectional radius of gyration RXS, based on the best fit lines as shown. TheQ ranges used for RXS analyseswere 1.2–1.6 nm
1 for dp6, 1.1–1.6 nm1 for dp8,
1.0–1.54 nm1 for dp10, 1.0–1.44 nm1 for dp12, 0.82–1.3 nm1 for dp14, and 1.0–1.4 nm1 for dp16, dp18, and dp24.
FIGURE 6. Experimental Guinier and P(r) x-ray data analyses of eight HS dp6–dp24 fragments. A, comparison of the experimental RG values fromGuinier
plots (‚) and P(r) curves (F) with the predicted RG values calculated from the linear models of Fig. 4 (E). The six corresponding values for heparin from Ref. 19
are denotedby and, respectively, and fitted to adotted line.B, comparisonof the experimental cross-sectionalRXS values (F) with thepredictedRXS values
calculated from the linearmodels of Fig. 4 (E). The corresponding four values for heparin dp18–dp36 fromRef. 19 are denoted by and fitted to a dotted line.
C, the distance distribution function P(r) analyses for dp6–dp24. The r values of themaximumatMwere 1.02 nm (dp6), 1.15 nm (dp8), 1.30 nm (dp10), 1.43 nm
(dp12), 1.44 nm (dp14), 1.61 nm (dp16), 1.87 nm (dp18), and 1.90 nm (dp24). The eight fragments are denoted by continuous, dashed, and dotted lines in
alternation.D, comparisonof theP(r) analyses forHSdp6–dp24withheparindp6–dp24. Thecurvescorrespondingtothe fourHSfragmentsdp6,dp12,dp18,and
dp24 are denoted by dashed lines, whereas the corresponding four curves for heparin are denoted by continuous lines. The heparin P(r) data are fromRef. 19.
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cylinder shape for HS; however, these approximate L values
show that the RG and RXS values are consistent with the P(r)
analyses. The P(r) curves also provide the most frequently
occurring interatomic distance, M, within the heparin struc-
ture from the r value of the peak maximum.M was observed at
r values that started at 1.02 nm for dp6 and increased to 1.90 nm
for dp24 (Fig. 6C). In conclusion, these comparisons show that
HS has a progressively more bent solution structure with
increase in size. Concurrently with this, the lengths, L, of HS
dp18 and dp24 are longer than those for the corresponding
heparin dp18 and dp24 fragments (Fig. 6D). Hence, HS is also
longer as well as being more bent than heparin.
Constrained Modeling of Eight HS Fragments—The experi-
mental x-ray RG and RXS values showed that the solution struc-
tures for HS is longer and more bent than those of heparin.
Here, constrained scattering modeling was performed with HS
to provide amolecular explanation of these scattering data. The
linear models created from the HS dp4 crystal structure were
the starting constraint. All eight HS fragments dp6–dp24 were
subjected to modeling. They were considered as belonging to a
structurally homologous series. As illustrated in the previous
modeling of heparin, the linkage connectivity between the
oligosaccharide rings was maintained (Fig. 1A), whereas the 
and  rotational angles at each glycosidic linkage was varied
randomly in a range of up to45° from their preceding values.
In all, 5,000–12,000 models for each of the eight HS fragments
were generated. For each fragment, x-ray scattering curves were
calculated from these randomizedmodels and fitted to the exper-
imental curve.TheRG,RXS, andR factor valueswere calculated for
eachmodeled curve, where theRG andRXS values were calculated
using the sameQ rangeused for the experimentalGuinier fits (Fig.
5, A and B), and the R factor is a measurement of goodness of fit.
The R factor distributions (supplemental Fig. S1, A–H) showed
that all the dp6–dp24 models (yellow circles) encompassed the
experimentalRG values (dashed lines) and that the lowestR factor
values were close to the 5–8% level usually expected for excellent
curve fits (47).
Totals of 5,000 models for dp6–dp10 and 8,000 models for
dp12–dp16 provided enough randomized conformers to be
able to determine best fit HS solution structures. Typically the
lowest R factors showed the best agreement with the experi-
mental x-ray curves. Near these minima, the best fit RG values
for dp6–dp16 (one red and seven cyan circles) agreed well with
the experimental RG values. The best fit RXS values for dp6–
dp16 also showed good agreement with the experimental RXS
values (supplemental Fig. S1, I–P). In distinction, the linear
models for the dp6–dp16 HS fragments showed greater devia-
tions from the experimental RG and RXS values (green circles).
These modeling analyses (Table 1 and Fig. 7) confirmed that a
nearly linear structure with slight bending accounted for the
x-ray and analytical ultracentrifugation data for dp6–dp16.
For HS dp6, the eight best fit models gave R factors of 4.4–
4.6%, RG values of 1.01–1.03 nm, RXS values of 0.30–0.32 nm,
and maximum lengths, L, of 3.0–3.1 nm. These agree well with
the experimental RG value of 1.03  0.08 nm, RXS value of
0.31  0.06 nm, and the P(r) length of 3.0 nm (Table 1). In
distinction to these agreements, the linear dp6model gave an R
factor of 4.1%, an RG value of 0.98 nm, and a L value of 3.0 nm.
The visual agreement between the experimental and modeled
I(Q) curves and P(r) curves was excellent (Fig. 7A). The calcu-
lated s020,w values from the eight best fit models gave 0.47–0.53
S. These values are lower but comparablewith the experimental
s20,w values of 0.82  0.05 and 1.05  0.04 S, given that the
typical accuracy of the s020,w calculation is 0.21 S (22).
For HS dp8, the modeling analyses indicated slightly bent
structures similar to those seen for dp6. The eight best fit mod-
els gaveR factors of 4.5%,RG values of 1.18–1.20 nm,RXS values
of 0.40 nm, and L values of 3.5–3.8 nm. These values agree well
with the experimental RG value of 1.19 0.08 nm, RXS value of
0.40  0.03 nm, and the P(r) length of 3.5 nm (Table 1). In
distinction to these agreements, the linear dp8 model again
showed a higher R factor of 4.8% and an RG value of 1.21 nm, an
RXS value of 0.43 nm, and a larger L value of 3.9 nm. The visual
agreement of the experimental and modeled I(Q) and P(r)
curves was excellent (Fig. 7B). The eight calculated s020,w values
of 0.61–0.62 S are smaller but comparable with the experimen-
tal s20,w values of 0.94 0.06 and 1.06 0.08 S.
For HS dp10, the modeling analyses showed good agree-
ments with slightly bent structures, inwhich the deviation from
a linear dp10 structure for dp10 was slightly increased. The
eight best fit dp10 models gave R factors of 44%, RG values of
1.40–1.42 nm, RXS values of 0.43–0.44 nm, and L values of
4.5–5.0 nm. These correspond well with the experimental RG
value of 1.41  0.07 nm, RXS value of 0.44  0.04 nm, and L
value of 4.5 nm (Table 1). The deviations from a linear dp10
model are larger, for which the R factor is 4.4%, the RG value is
1.44 nm, theRXS value is 0.47 nm, and the L value is 4.4 nm. The
visual agreement of the experimental and modeled I(Q) and
P(r) curves was again excellent (Fig. 7C). The eight modeled
s020,w values of 0.67–0.68 S are again comparable with the
experimental s20,w values of 0.95 0.09 and 1.09 0.06 S.
For HS dp12, the modeling analyses were also successful, in
which the deviation from a linear dp12 structure was greater.
The eight best fit models gave R factors of 4.2–4.5%, RG values
of 1.63–1.65 nm, RXS values of 0.48–0.50 nm, and L values of
5.5–5.7 nm. These agree well with the experimental RG value of
1.65 0.09 nm, theRXS value of 0.49 0.04 nm, and the L value
of 5.5 nm (Table 1). The linear dp12 model showed a higher R
factor of 4.5%, a higherRG value of 1.68 nm, a reducedRXS value
of 0.42 nm, and a longerL value of 5.7 nm.The visual agreement
of the experimental and modeled I(Q) and P(r) curves was
excellent (Fig. 7D). The eightmodeled s020,w values of 0.74 S are
comparable with the experimental s20,w values of 1.08  0.09
and 1.16 0.05 S.
For HS dp14, good agreements between the models and
experimental data were obtained, whereas the deviation from a
linear dp14 structure was larger. The eight best fit dp14models
gave R factors of 4.3%, RG values of 1.73–1.76 nm, RXS values of
0.48–0.49 nm, and L values of 6.0–6.3 nm. These values agree
well with the experimental RG value of 1.76 0.07 nm, the RXS
value of 0.51  0.02 nm, and the L value of 6.0 nm (Table 1).
These values deviated from the linear dp14 model, which had
an R factor of 4.7%, a higher RG value of 1.91 nm, a lower RXS
value of 0.38 nm, and an L value of 7.0 nm. Again the visual
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agreement of the experimental and modeled I(Q) and P(r)
curves was excellent (Fig. 7E). The eight modeled s020,w values
of 0.82–0.83 S compare well with the experimental s20,w value
of 1.07 0.07 and 1.18 0.04 S, respectively.
For HS dp16, the outcome of themodeling analyses was sim-
ilar to that of dp14. The eight best fit models gave R factors of
6.5–6.6%, RG values of 1.93–2.00 nm, RXS values of 0.49–0.51
nm, and L values of 6.4–7.2 nm. These agree well with the
experimental RG value of 2.03  0.07 nm, the RXS value of
0.52 0.01 nm, and the L value of 7.0 nm (Table 1). The linear
dp16 model gave a poorer fit with an R factor of 6.7%, an RG
value of 2.15 nm, an RXS value of 0.38 nm, and an L value of 8.5
nm. The experimental and modeled I(Q) and P(r) curves
showed excellent agreement (Fig. 7F). The eight modeled s020,w
values of 0.86–0.89 S are comparable with the experimental
s20,w values of 1.10 0.03 and 1.24 0.08 S.
Of interest were the different outcomes seenwithHSdp18 or
dp24, starting from 12,000 randomized models for these two
HS structures. Following the procedures used for dp6–dp16,
the best fit extendedmodels for dp18 and dp24 gave reasonable
R factors of 6.2–7.9%. For extended dp18, modeled RG values of
2.24–2.29 nm, RXS values of 0.39–0.48 nm, and L values of
8.0–8.5 nmwere obtained. Unlike dp6–dp16, the modeled RG
and RXS values were less than the experimental RG value of
2.34 0.03 nm and the RXS value of 0.61 0.05 nm (Table 1).
As expected, the linear model gave a poorer fit with an R factor
of 8.2%, RG value of 2.22 nm, an RXS value of 0.31 nm, and an L
value of 8.9 nm. For extended dp24,modeledRG values of 2.68–
2.78 nm, RXS values of 0.52–0.58 nm, and L values of 9.0–10.0
nm were obtained. The modeled RG and RXS values were also
less than the experimental RG value of 2.82 0.10 nm and the
RXS value of 0.65  0.05 nm (Table 1). The linear model also
gave a poorer fit with an R factor of 11.9%, an RG value of 2.72
nm, anRXS value of 0.43 nm, and anL value of 11.0 nm.Notably,
the RG values of 2.13 nm (dp18) and 2.47 nm (dp24) at the R
factor minima of supplemental Fig. S1 (G and H) (Table 1) did
not coincide with the experimental RG values of 2.34 nm (dp18)
and 2.82 nm (dp24). Better agreements were observed for more
bentmodels (Table 1). These differences inRG values suggested
that conformational heterogeneity between extended and bent
structures was present, i.e., dp18 and dp24 exhibited multiple
conformations in solution. The experimental andmodeled I(Q)
and P(r) curves showed good visual agreements for either con-
formation (Fig. 7,G andH). For dp18, themodeled s020,w values
of 0.90–0.92 S (extended) or 0.90–0.94 S (bent) were similar to
the experimental s20,w values of 1.12 0.06 and 1.25 0.07 S,
with the best fitmodels giving two values of 0.92 S. For dp24, the
modeled s020,w values of 0.91–1.0 S (extended) or 0.78–1.07 S
(bent) were similar to the experimental s20,w values of 1.26 
0.06 S and 1.34  0.06 S, with the two best fit models giving a
value of 0.96 or 1.07 S.
DISCUSSION
The size and spacing of Sdomains inHS are proposed to be as
important to its biologically significant interactions with pro-
teins as are the detailed sequences of the S domains themselves
(49). Heparin, a commonly usedmodel compound for HS, con-
sists of lengthy S domains, made up largely of the repeating
trisulfated disaccharide shown in Fig. 1B, separated by much
smaller, unsulfatedNA domains. In HS the position is reversed,
and long NA domain sequences (Fig. 1A) act as spacers to sep-
arate the short S domains. Although the S domain conforma-
tion, exemplified by heparin, has been the subject of numerous
studies (50), the NA domain has not. It has been proposed that
the NA domain repeating sequences are both less flexible (51)
and more flexible (52) than the S domains.
The application of constrained scattering modeling has
proved to be as effective for the HS fragments as it was for
heparin previously. Usually scattering fits are performed for
protein structures of size 20–100 kDa and higher (21, 22). The
HS fragments dp6–dp24 and the heparin fragments dp6–dp36
are notably smaller in size with masses of 1–7 and 2–11 kDa,
respectively. The ability to measure their scattering curves was
attributed to the high x-ray beam intensity and low back-
grounds at the instrument, together with improved detector
technology. Constrained scattering modeling determines a
three-dimensional molecular structure that best accounts
for the observed scattering curve through trial and error
searches that rule out structures that are incompatible with the
observed scattering curves. By fixing the analyses to what is
already known about the macromolecule, namely the carbohy-
drate rings, and varying only the and angles of each glyco-
sidic linker, relatively fewmodeling variables are involved in the
scattering fits. Through the variation of and, the resulting
5,000–12,000 models provided sufficient statistical detail to
result in clear V-shaped graphs of R factor versus RG and R
factor versus RXS values. The best fit models were identified by
the lowest R factors, and they were verified by the agreement
of the modeled and experimental RG and RXS values at this
point. The quality of the HS dp6–dp16 scattering fits was sim-
ilar to those of the heparin dp18–dp36 fits (19). Interestingly,
different fits were obtained for the HS dp18 and dp24 struc-
tures. The monodispersity of these two fragments had been
established by the single peaks seen in the ultracentrifugation
c(s) analyses (Fig. 3); thus the potential contribution of sample
heterogeneity in dp18 and dp24 can be ruled out as an explana-
tion for the different fits. The ability to fit either extended or
bent HS dp18 and dp24 structures to the scattering curves
resulted in the conclusion of multiple conformations for HS
dp18 and dp24. Thismodeling outcome is distinct from that for
heparin dp6–dp36, where only single conformations were
FIGURE 7.X-raymodeling curve fits for best fit and poor fit HS dp6–dp24models. Themain panels (A–H) depict the I(Q) curve fits, and the insets show the
P(r) distance distribution function fits. The experimental I(Q) and P(r) scattering data are represented by black circles or lines, respectively; the red lines and
models correspond to the best fit dp6–dp24 models from the trial and error searches; and the green lines and models correspond to the linear poor fit
dp6–dp24models from Fig. 4. The best fit and linear models are shown in the left lower corner, together with their maximum lengths L in nm for comparison
with the experimental L values in the P(r) curves. For dp18 and dp24, the best fit model identified from only the minimum R factor value as filter is shown in
purple.
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required for good fits. This outcome suggested that the heparin
structures show greater rigidity than the HS structures.
The HS fragments used in this study were produced by exten-
sive depolymerization using heparinase 1, an enzyme that cleaves
only within the S domains (28) leavingNA domains untouched. It
is therefore likely that some minor degree of sulfation remains at
the reducing and nonreducing end of our fragments, but that
internal disaccharides areunsulfated. Such fragmentsbear a closer
resemblance toNAdomainsof intactHSthan themost commonly
usedmodel compound for this sequence, the capsular polysaccha-
ride from Escherichia coli K5 (51, 52). These structures provide
novel comparative insight into the structures of HS and heparin,
and the likelymanner that these two polyanionic oligosaccharides
interactwith their protein ligands.HSandheparinboth share sim-
ilar covalent structures (Fig. 1). The comparison of our two sets of
structures for HS and heparin becomes essentially that between
NA and Sdomains. The greater bending and flexibility ofHS com-
pared with heparin (see Fig. 9) may be attributed to the difference
in uronic acid residue, in which GlcNAc alternates with GlcA in
HS, causingHS to adopt a distinct conformation from that of fully
sulfated heparin (53).
More detailed inspection of the best fit models for HS dp6–
dp16 clarifies their progressively more bent structures in solu-
tion with increase in HS size. This outcome is visible from the
superimposition of the eight best fit models for each HS frag-
ment (Fig. 8). When comparing the solution structures of hep-
arin dp18 and dp24 (Fig. 8 of Ref. 19) with those of HS dp18 and
dp24, the HS structures were visibly more bent than those of
heparin (Fig. 9A). Crystal structures containing HS or heparin
showed that the glycosidic linkage in HS has a similar length to
that in heparin (Fig. 9B). In HS, the separation between the
C1–C4 atoms of GlcA-GlcNAc is 0.237  0.003 nm and that
between GlcNAc-GlcA is 0.235 0.002 nm. For heparin, anal-
yses of five crystal structures containing dp6 showed that very
similar separations were seen between IdoA-GlcNS of 0.241
0.004 nm and between GlcNS-IdoA of 0.243 0.006 nm. Thus
the increased length ofHS in solution comparedwith heparin is
mostly the consequence of altered and angles. In terms of
rotational bend, it is already known that the crystallographic
and angles for smaller HS and heparin structures agree with
each other within error (Table 2 and supplemental Fig. S2). The
 and  angles for HS dp6–dp24 were all similar, including
FIGURE 8. Superimposition of the eight best fit models for each of the eight HS dp6–dp24 fragments. Each set of eight best fit models for the eight HS
fragments were superimposed globally using Discovery Studio VISUALISER software, and their non-hydrogen atoms are displayed as shown. Each best fit
model from Fig. 7 is shown in black, whereas the seven related best fit structures are shown in gray. For dp18 and dp24, both the overall extended best fit
structures (filtering on RG, RXS, and R factor values) and the bent best fit structures (filtering on R factor values only) are shown.
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those in the small crystal structures (Table 2). The linkage
geometries of our HS models fall approximately into the low
energy regions for (134) and (134) linkages between glu-
cose residues, as determined for maltose and cellobiose by
experimental and theoretical methods (48). Thus the mean 
and angles for the GlcA-GlcNAc linkage were85 and 127°
in HS, being similar but not identical with the corresponding
IdoA-GlcNS values of 61 and 132° in heparin. The mean 
and angles for theGlcNAc-GlcA linkagewere 85 and 91° inHS,
close to the corresponding values of 98 and 86° forGlcNS-IdoA in
heparin (Table 2). The distribution of the  and  values in
supplemental Fig. S2 (A and B) showed low rotational variability
at both glycosidic linkages inHS.These distributionswere in good
accord with those for heparin in supplemental Fig. S2 (C andD).
In conclusion, the more bent structure in solution for HS than
for heparin (Fig. 9A) is attributed to small but reproducible
differences of 24 and 13° for the two angles of heparin andHS
(Table 2). In contrast, the two angles of heparin andHS differ
by only 5°.
The solution structures of the HS dp6–dp24 fragments
exhibited bending and flexibility (Figs. 8 and 9A). In addition,
the HS structures are slightly longer for reason of alterations in
the glycosidic and angles (supplemental Fig. S2). The phys-
ical basis for these changes in HS is likely to arise from the
GlcA-GlcNAc sequences (as opposed to the IdoA-GlcNS
sequences in heparin). Unlike HS, heparin will be influenced by
greater repulsion between regular repeats of sulfate-sulfate, sul-
fate-carboxylate, and carboxylate-carboxylate groups. The
combination of the NA and S domain structures within the
parent HS structure suggests that different parent HS struc-
tures with greater or lesser bending may arise through varia-
tions of the ratio in sizes of the NA and S domains. These vari-
ations are likely to be as important as the fine structure of the
individual domains in the physiological functions of these com-
plex glycosaminoglycans (49, 55).
In terms of biological function, the greater degree of bending in
HS accounts for the ability of HS to bind to a diverse range of
protein ligands in all orientations. This will facilitate the assembly
of large multipartner complexes on cell surfaces such as those
involving the 20-domain structure of complement factor H (56).
The outcome of 19 protein-heparin crystal structures has been
discussed previously (19), whereas only one protein-HS crystal
structure is known (20). It was of interest that the and angles
for the HS crystal structure are similar to those seen in the 19
heparin-protein crystal structures (Table 2). In addition, themean
 and angles for HS in solution are similar and close to those
seen by crystallography for HS dp4. Several studies of HS-protein
interaction have noted that SAS sequences, in which two short S
domains are separated by anNA sequence, are preferred for opti-
mumbinding (48). This is particularly true for oligomeric proteins
FIGURE 9. Comparison of the best fit HS dp6–dp24 structures with the
equivalentheparindp6–dp24structures.Red, carbonandoxygen;blue, nitro-
gen; yellow, sulfur. A, four best fit HS models (dp6, dp12, dp18 (extended), and
dp24 (extended)) are compared with the heparin dp24model at the bottom all
drawn to the same scale. The lengths of heparin dp6, dp12, dp18, and dp24 are
indicated above the heparin dp24 structure for comparison with HS. B, the gly-
cosidic linkages in the crystal structure of HS dp4 complexed with heparinase II
(PDB code 3E7J) are comparedwith the crystal structure of the complex of hep-
arindp4with fibroblast growth factor (PDBcode1BFB). The anomeric configura-
tions of the glycosidic linkers are shown as or.
TABLE 2
Summary of the and angles in the crystal and solution structures
of HS and heparin
a The mean value from two HS dp4 molecules seen in the crystal structure (PDB
code 3E7J).
b The average is calculated from all the  and angles in the eight best fit models.
c The average is calculated from the heparin models of Ref. 19.
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such as, for example, MIP-1a or platelet factor 4 (7, 57). In these
cases, the multiple heparin-binding sites on the oligomer are not
always arranged in a linear way, so that a single long S domain
cannot readily bind tomore thanone site on the samemultimer. It
has been reasonable to suppose that NA domains, composed of
alternating(134)- and(134)-linkedhexopyranoses,would be
more flexible than the unusually stiff heparin structure of S
domains, allowing an SAS domain to bend to present two S
domains to heparin-binding sites on opposite sides of a protein
complex. The conclusion from our present study of HS NA frag-
ments supports this intuitive reasoning.
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Addendum—In our originally reported HS best fit structures (58),
the anomeric configurations of the GlcA and GlcNAc residues should
have alternated between  and . Instead, the anomeric configurations
were all  in our original HS models. The present study replaces our
original study (58), which has now been withdrawn. The error was
traced back to a misunderstanding of the starting HS structure in the
ProteinData Bank, andwe take full responsibility for ourmistake. First,
the dp4 structure had been written out in the original crystallography
paper (20) as NAG-GCU-NAG-GCD (where NAG is the PDB code for
GlcNAc,GCUis the code forGlcA, andGCDis the code forUA).This
order, with the reducing end to the left, is unconventional and was a
contributing factor to our misunderstanding. Second, the use of the
termsNAGandGCUcorresponded to the-GlcNAc and-GlcA ano-
mers, respectively, in the PDBdictionary. In fact,HS is comprised of the
-GlcNAc and -GlcA anomers and should have been described as
NDGandBDP in theHSdp4 crystal structure (PDBcode 3E7J). Inspec-
tion of PDBdepositions containingGCU showed the existence of other
terminological confusions. Several relatively recent structures in the
PDB use GCU for internal -GlcA residues, possibly following the
example of the classic hyaluronate and chondroitin sulfate studies (PDB
codes 1HYA, 2HYA, 4HYA, 1C4S, and 2C4S). In addition to the PDB
code 3E7J of the present study, the structures of bee venom hyal-
uronidase with a hyaluronate tetrasaccharide (PDB code 1FCV) and
CD44 with a hyaluronate octamer (PDB code 2JCQ) use GCU and not
BDP.ThePDBstructure 2JCR (fromthe same study asPDBcode2JCQ)
uses the correct term BDP. Related discrepancies in the PDB have also
been reported by others (54, 59).
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